Indication
Hyperammonemia due to methylmalonic acidemia
Hyperammonemia due to methylmalonic acidemia is a severe, life-threatening metabolic complication in patients with methylmalonic acidemia, an inherited organic acid disorder primarily affecting neonates, infants, and young children. Read more about Hyperammonemia due to methylmalonic acidemia
4 drugs 4 manufacturers
Drugs that treat it
Common Hyperammonemia due to methylmalonic acidemia therapies.
CARBAGLU (carglumic acid)
CARGLUMIC ACID
CARGLUMIC ACID
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHyperammonemia due to methylmalonic acidemia is a severe, life-threatening metabolic complication in patients with methylmalonic acidemia, an inherited organic acid disorder primarily affecting neonates, infants, and young children.
It occurs when an enzymatic defect in methylmalonyl-CoA mutase or its cobalamin cofactors leads to the toxic accumulation of organic acid intermediates, such as methylmalonic acid and propionyl-CoA.
These metabolites secondary inhibit hepatic urea cycle function—specifically carbamoyl phosphate synthetase 1 and N-acetylglutamate synthase—preventing normal nitrogen clearance and triggering rapid ammonia accumulation.
Clinically, affected patients present with acute encephalopathy, vomiting, lethargy, seizures, high anion gap metabolic ketoacidosis, and a high risk of cerebral edema.
- nih.gov
Hyperammonemia due to methylmalonic acidemia is a severe, life-threatening metabolic complication in patients with methylmalonic acidemia, an inherited organic acid disorder primarily affecting neonates, infants, and young children
- tandfonline.com
Hyperammonemia due to methylmalonic acidemia is a severe, life-threatening metabolic complication in patients with methylmalonic acidemia, an inherited organic acid disorder primarily affecting neonates, infants, and young children It occurs when an enzymatic defect in methylmalonyl-CoA mutase or its cobalamin cofactors leads to the toxic accumulation of organic acid intermediates, such as methylmalonic acid and propionyl-CoA Clinically, affected patients present with acute encephalopathy, vomit...
- nih.gov
Hyperammonemia due to methylmalonic acidemia is a severe, life-threatening metabolic complication in patients with methylmalonic acidemia, an inherited organic acid disorder primarily affecting neonates, infants, and young children
- researchgate.net
It occurs when an enzymatic defect in methylmalonyl-CoA mutase or its cobalamin cofactors leads to the toxic accumulation of organic acid intermediates, such as methylmalonic acid and propionyl-CoA
- nih.gov
These metabolites secondary inhibit hepatic urea cycle function—specifically carbamoyl phosphate synthetase 1 and N-acetylglutamate synthase—preventing normal nitrogen clearance and triggering rapid ammonia accumulation
- uspto.gov
These metabolites secondary inhibit hepatic urea cycle function—specifically carbamoyl phosphate synthetase 1 and N-acetylglutamate synthase—preventing normal nitrogen clearance and triggering rapid ammonia accumulation
- newenglandconsortium.org
Clinically, affected patients present with acute encephalopathy, vomiting, lethargy, seizures, high anion gap metabolic ketoacidosis, and a high risk of cerebral edema
- aasld.org
Clinically, affected patients present with acute encephalopathy, vomiting, lethargy, seizures, high anion gap metabolic ketoacidosis, and a high risk of cerebral edema
Personalize your experience
Follow Hyperammonemia due to methylmalonic acidemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.